SUMMARY
In the absence of low-level ER-to-mitochondrial Ca 2+ transfer, ATP levels fall, and AMPK-dependent, mTOR-independent autophagy is induced as an essential survival mechanism in many cell types. Here, we demonstrate that tumorigenic cancer cell lines, transformed primary human fibroblasts, and tumors in vivo respond similarly but that autophagy is insufficient for survival, and cancer cells die while their normal counterparts are spared. Cancer cell death is due to compromised bioenergetics that can be rescued with metabolic substrates or nucleotides and caused by necrosis associated with mitotic catastrophe during their proliferation. Our findings reveal an unexpected dependency on constitutive Ca 2+ transfer to mitochondria for viability of tumorigenic cells and suggest that mitochondrial Ca
INTRODUCTION
Inositol 1,4,5-trisphosphate receptors (InsP 3 Rs) are a ubiquitous family of Ca 2+ release channels present primarily in the ER (Foskett et al., 2007) . Ca 2+ release through the InsP 3 R regulates numerous cell functions, including transcription, proliferation, secretion, and motility, among others (Cá rdenas et al., 2005; Foskett et al., 2007) . InsP 3 R-mediated Ca 2+ signals also regulate cell metabolism, primarily by supplying released Ca 2+ to mitochondria, where it stimulates production of reducing equivalents by pyruvate dehydrogenase (PDH) and two Ca 2+ dependent dehydrogenases in the tricarboxylic acid (TCA) cycle, a-ketoglutarate dehydrogenase (a-KGDH) and isocitrate dehydrogenase (IDH) (McCormack and Denton, 1979) , as well as activities of respiratory chain components to promote oxidative phosphorylation (OXPHOS) and ATP production (Murphy et al., 1990; Territo et al., 2000) . Low-level constitutive InsP 3 R-mediated Ca 2+ release is essential for maintaining basal levels of OXPHOS and ATP production in a wide variety of cell types (Cá rdenas et al., 2010) . In the absence of constitutive ER-to-mitochondrial Ca 2+ -transfer, ATP levels fall and AMPK-dependent, mTOR (mammalian target of rapamycin)-independent autophagy is induced (Cá rdenas et al., 2010; Mallilankaraman et al., 2012a Mallilankaraman et al., , 2012b as an essential survival mechanism (Cá rdenas et al., 2010) . In all cell types examined, inhibition of constitutive mitochondrial Ca 2+ uptake induced a bioenergetic crisis that resulted in a reprogramming of metabolism reminiscent of that induced by nutrient starvation, despite nutrient availability and enhanced nutrient uptake. A hallmark feature of cancer cells is a re-programming of their metabolism, even when nutrients are available (Boroughs and DeBerardinis, 2015; Jones and Thompson, 2009; Jose et al., 2011) . All major tumor suppressors and oncogenes have connections with metabolic pathways (Deberardinis et al., 2008; Koppenol et al., 2011; Levine and Puzio-Kuter, 2010; Vander Heiden et al., 2009 ). Warburg suggested that cancer originates from irreversible injury in mitochondria, followed by a compensatory increase of glycolysis (Warburg, 1956 ), but increasing evidence indicates that mitochondrial function is essential for cancer cells (Koppenol et al., 2011) . A continuous supply of metabolic intermediates from the TCA cycle fuels lipid, nucleic acid, and protein biosynthesis and provides redox power essential for cancer cell proliferation (Boroughs and DeBerardinis, 2015; Deberardinis et al., 2008) . Many tumor cells require OXPHOS to maintain growth (Birsoy et al., 2014; Caro et al., 2012) and for the majority of their ATP production (Jose et al., 2011) . Mutations in OXPHOS genes are tumorigenic (Bayley and Devilee, 2010) , and mitochondrial inhibitors have antitumor activity Momose et al., 2010; Zhang et al., 2014) .
Accordingly, here, we asked what role constitutive mitochondrial Ca 2+ uptake, important in normal cell bioenergetics, plays in cancer cell metabolism and viability. Using tumorigenic breast and prostate cancer cell lines and genetically transformed isogenic primary human fibroblasts, we found that interruption of constitutive ER-to-mitochondrial Ca 2+ transfer elicited effects similar to those observed in normal cells, including diminished OXPHOS, AMPK activation, and induction of autophagy. Whereas autophagy was sufficient for survival of normal cells, it was insufficient in cancer cells, which responded strikingly with massive death, while their normal counterparts were spared. Furthermore, inhibition of InsP 3 R activity strongly suppressed melanoma tumor growth in mice. Addition of metabolic substrates or nucleotides rescued the lethal effect of inhibiting mitochondrial Ca 2+ uptake, suggesting that cell death was induced by compromised bioenergetics. Cell death was caused by necrosis associated with mitotic catastrophe at daughter cell separation during ongoing proliferation of the cancer cells. Our findings reveal a fundamental and unexpected dependency on InsP 3 R-mediated Ca 2+ transfer to mitochondria for viability of cancer cells.
RESULTS

Inhibition of InsP 3 R Activity Creates a Bioenergetic Crisis in Both Tumorigenic and Non-tumorigenic Cell Lines
We examined the effects of InsP 3 R inhibition on metabolic responses of human breast-and prostate-cancer-derived tumorigenic cell lines. As controls, we examined non-tumorigenic lines derived from normal tissues. XeB (5 mM, 1 hr), a specific InsP 3 R inhibitor , reduced basal and maximal oxygen consumption rates (OCRs) ( Figure 1A ), enhanced AMPK phosphorylation (P-AMPK) ( Figure 1B) , and induced autophagic flux in both non-tumorigenic and tumorigenic breast (Figures 1C, S1A, and S1B) and prostate ( Figures S2A and S2B ) cell lines. The effects of XeB on bioenergetic parameters were dose dependent, with 5 mM as the minimum concentration required to strongly induce autophagy and significantly reduce basal and maximal OCRs in both MCF10A and MCF7 cells (Figures S1C-S1F). Similar responses to InsP 3 R inhibition, including decreased OCR, increased P-AMPK, and induction of autophagy were observed in mouse melanoma B16F10 cells , demonstrating that this is a non-species-specific general phenomenon. Thus, XeB generates similar bioenergetic crises in tumorigenic and non-tumorigenic cell lines. XeB inhibited constitutive and spontaneous Ca 2+ transients in both MCF10A and MCF7 cells (Figures 1D and S1G; Movie S1 [MCF7] ; Movie S2 [MCF10A]). Furthermore, simultaneous genetic knockdown (KD) of InsP 3 R types 1 and 3 (50%-70% efficiency; Figure S1H ), the main isoforms expressed in these cells (Figures S1I-S1K), created a similar bioenergetic crisis in normal and tumorigenic cells ( Figures 1E and 1F ).
Inhibition of InsP 3 R Activity Is Toxic, Specifically for Tumorigenic Cells Breast cells were treated with XeB for 24 hr, and cell viability was assessed by flow cytometry. 2.5 mM XeB had little effect, except for tumorigenic HS578T cells, in which death was enhanced by 8% ± 1% (Figure 2A ). In contrast, 5 mM XeB induced substantial death by 43% ± 4% and 53% ± 2% in tumorigenic MCF7 and T47D cell lines, respectively, and over 22% ± 1% in HS578T cells. In contrast, non-tumorigenic MCF10A cells showed only limited sensitivity (5% ± 0.4% cell death). At 10 mM, XeB killed 63% ± 7% and 64% ± 5% of MCF7 and T47D cells, respectively, and 42% ± 6% of HS578T cells, whereas MCF10A cells had only modest sensitivity (24% ± 1%) ( Figure 2A ). Similar XeB-mediated killing was observed in human-cancer-derived prostate cell lines PC3 and DU145, but there was little effect for the non-tumorigenic PNT2 prostate line ( Figure S2C ). In agreement with results from flow cytometry, XeB caused striking lactate dehydrogenase (LDH) release in all tumorigenic breast lines, compared with MCF10A cells (Figure 2B ), as well as in mouse melanoma B16F10 cells ( Figure S2I ). As assessed by both flow cytometry and LDH release ( Figures 2C and 2D ), tumorigenic lines started dying as early as at 6 hr of exposure to 5 mM XeB, while the non-tumorigenic cells remained insensitive. The observed differences in XeB sensitivity could not be accounted for by intrinsic differences in proliferation rates between cell lines in untreated conditions (Figures S1L and S2E) . Tumorigenic breast ( Figure 2E ) and prostate ( Figure S1D ) cells exposed to XeB (5 mM for 24 hr) displayed striking morphological changes, including rounding up and shrinkage, whereas similarly treated non-tumorigenic cells maintained normal morphology.
These results suggest that tumor cell survival is dependent upon InsP 3 R signaling. In agreement, inhibition of phospholipase C (PLC), the enzyme responsible for the generation of the InsP 3 R ligand InsP 3 , with U73122 (2 mM), but not the inactive analog U73343, caused striking LDH release in all tumorigenic breast cell lines, with substantially less effects in the non-tumorigenic line ( Figure 2F ). Similarly, simultaneous genetic KD of InsP 3 R types 1 and 3 caused comparable LDH release as XeB and U73122 in MCF7 and T47D cells, while non-tumorigenic MCF10A cells showed only a small increase ( Figure 2G ). Thus, tumorigenic cell lines appear to have an essential dependence on InsP 3 R-mediated Ca 2+ signaling for survival, unlike normal cells.
Inhibition of InsP 3 R Activity Reduces the Proliferative Potential of Cancer Cell Lines
Colony formation is a hallmark of cancer cells that reflects their ability to proliferate indefinitely (Munshi et al., 2005) . XeB (5 mM, 24 hr) diminished colony formation by tumorigenic breast MCF7 ( Figure 3A ) and T47D cells and prostate PC3 cells (Figures S3A and S3B) . In normal cells, the bioenergetic crisis caused by inhibition of InsP 3 R activity could be overcome by providing pyruvate as a mitochondrial substrate, presumably by mass action to drive flux through the system (Cá rdenas et al., 2010) . Methyl-pyruvate (5 mM, 24 hr) rescued the XeB-induced MCF7 colony formation defect ( Figure 3B ). Pyruvate has antioxidant properties (Andrae et al., 1985) . However, XeB did not enhance reactive oxygen species (ROS) production ( Figure S3C ), and N-acetylcysteine (NAC) (5 mM, 24 hr) did not rescue colony formation ( Figure 3B ) or prevent XeB-induced AMPK activation ( Figure S3D ), autophagy ( Figure S3E ), or MCF7 cell death (Figure S3F ). These results suggest that cancer cell killing and reduction of colony formation by inhibition of InsP 3 R activity is a consequence of a bioenergetic crisis that can be rescued by a mitochondrial substrate, but not by an antioxidant.
XeB Induces Cell Death in Transformed, But Not Isogenic Control, Human Fibroblasts Although the cell lines are well validated and broadly used models, the fact that the control lines are also transformed complicates the results. Therefore, we turned to an isogenic primary human fibroblast model. Primary human fibroblasts were transformed by the incorporation of oncogenic HRas G12V while bypassing retinoblastoma (Rb)-mediated G1 cell-cycle restraint by enforced expression of cyclin-dependent kinase-4 (Cdk4) (Ridky et al., 2010) . This model (HrasG12V-CDK4) has classic cancer features, including invasive properties. HrasG12V-CDK4 fibroblasts showed elevated glucose consumption (Figure S3G) and lactate release ( Figure S3H ), consistent with acquisition of a Warburg-type metabolism. Nevertheless, control and transformed cells had comparable OCRs, suggesting similar OXPHOS ( Figure 4A ). Furthermore, the OCR was reduced by XeB to a similar extent in HrasG12V-CDK4 and isogenic control cells ( Figure 4A ), and a bioenergetic crisis ensued, as evidenced by increased P-AMPK and induction of autophagy (Figures 4B and 4C) . These results suggest that mitochondria remain important for maintenance of cell bioenergetics in these primary transformed cells.
As in the cancer cell lines, XeB induced profound morphological changes and reduced the number of HrasG12V-CDK4 cells per field, whereas isogenic controls behaved similarly to vehicletreated cells ( Figure S3I ). LDH release was enhanced 6-fold in HrasG12V-CDK4 cells, compared with isogenic controls (Figure 4D ). The sensitivity of HrasG12V-CDK4 cells compared with that of isogenic cells could not be accounted for by differences in their normal rates of proliferation ( Figure S3J ). Simultaneous KD of InsP 3 R types 1 and 3, the main isoforms in these cells enhanced P-AMPK and autophagy in both HrasG12V-CDK4 and isogenic control fibroblasts ( Figure 4E and 4F), but it caused significant death, specifically in the HrasG12V-CDK4 cells ( Figure 4G ). Thus, in primary human cells, as in breast and prostate cell lines, inhibition of InsP 3 R activity is strongly toxic specifically for cancer cells.
Killing of Cancer Cells by Inhibition of InsP 3 R Activity Is Mediated by Altered Mitochondrial Function
In normal cells, inhibition of mitochondrial Ca 2+ uptake phenocopies the effects of InsP 3 R inhibition on cell bioenergetics, suggesting that the primary role of InsP 3 R activity in preserving normal cellular bioenergetics is to provide Ca 2+ to mitochondria (Mallilankaraman et al., 2012a) . The similar bioenergetic responses to inhibition of InsP 3 R activity of tumor cell lines and HrasG12V-CDK4 cells suggested that cancer cells may have a similar dependence on constitutive mitochondrial Ca 2+ uptake. To test this, we knocked down in HrasG12V-CDK4 and isogenic control cells the expression of MCU, the pore-forming subunit of the mitochondrial uniporter Ca 2+ channel, the major Ca 2+ uptake pathway in mitochondria (Foskett and Philipson, 2015) . MCU expression was similar in human normal versus transformed fibroblasts or between the MCF10A and MCF7 cells (Figures S4E and S4F) . MCU KD ( Figure S4E ) increased P-AMPK and induced autophagy (Figures 4E and 4F) , as in normal cells (Mallilankaraman et al., 2012a (Mallilankaraman et al., , 2012b . Importantly, MCU KD enhanced killing preferentially of the HrasG12V-CDK4-transformed cells ( Figure 4G ). In contrast, overexpression of MCU was unable to protect MCF7 cells from death induced by InsP 3 R inhibition with XeB ( Figures S4G and S4H ). These results suggest that InsP 3 R-mediated Ca 2+ release and its transfer to mitochondria through MCU are essential to maintain cancer cell viability. (A) Non-tumorigenic and tumorigenic human breast cell lines were treated with XeB for 24 hr, and cell death was determined by TOTO-3 incorporation by flow cytometry. n = 3, mean ± SEM. ***p < 0.001; NS, not significant (one-way ANOVA followed by Dunnett's multiple comparison post test).
(B) Breast cell lines were treated with 5 mM XeB for 24 hr, and cell death was determined by LDH release. n = 3, mean ± SEM. *p < 0.05; ***p < 0.001 (Student's t test).
(C) Time course of cell death determined by TOTO-3 incorporation by flow cytometry in human breast cell lines treated with 5 mM XeB. n = 3, mean ± SEM. *p < 0.05; ***p < 0.001 (Student's t test).
(D) Time course of cell death determined by LDH release in breast cell lines treated with 5 mM XeB. n = 3, mean ± SEM. *p < 0.05; ***p < 0.001 (Student's t test).
(E) Differential interference contrast (DIC) images of breast cell lines derived from non-tumorigenic (MCF10A) or tumorigenic (MCF7, T47D, HS578T) human tissue treated with 5 mM XeB for 24 hr. Scale bar represents 10 mm. n = 3. (F) Non-tumorigenic and tumorigenic breast cell lines were treated with 2 mM of the PLC inhibitor U73122 or its inactive analog U73343 for 12 hr, and cell death was determined by LDH release. n = 3, mean ± SEM. ***p < 0.001; NS, not significant (Student's t test).
(G) Cell death (LDH release) in human breast cell lines transiently transfected with a siRNA against type 1 and type 3 InsP 3 R (IP3R KD) or a scrambled non-target (S) siRNA for 24 hr. n = 3, mean ± SEM. ***p < 0.001; NS, not significant (Student's t test). See also Figure S1 .
The TCA cycle is regulated by product inhibition, substrate availability, and cofactors, including Ca 2+ . PDH, IDH, and a-KGDH activities are all critically regulated by mitochondrial matrix Ca 2+ (Glancy and Balaban, 2012) . Inhibition of InsP 3 Rmediated Ca 2+ release reduces PDH activity, resulting in decreased OCR and ATP production (Cá rdenas et al., 2010) . Cancer cells rely on mitochondria for production of TCA intermediates needed for high growth and proliferation (Boroughs and DeBerardinis, 2015) . We speculated that inhibition of mitochondrial function by the absence of sufficient matrix Ca 2+ cannot be compensated for, specifically in cancer cells, because of this dependence on the TCA cycle. Addition of dimethyl a-KG or methyl-pyruvate, two substrates that energize mitochondria (Cá rdenas et al., 2010; Wise and Thompson, 2010) to XeBtreated (5 mM, 24 hr) fibroblasts strongly reduced cell death (Figure 4H) . Protection was unrelated to antioxidant properties of the substrates, since NAC (5 mM) was without effect on XeBinduced P-AMPK ( Figures S4I and 4K ), autophagy ( Figures S4J  and S4L ), or killing ( Figure S4M ). Although enhanced P-AMPK indicates that inhibition of InsP 3 R-mediated Ca 2+ transfer to mitochondria lowers cellular ATP (Cá rdenas et al., 2010) , glycolysis is believed to provide sufficient ATP for cancer cell functions (Deberardinis et al., 2008) . However, as highly proliferative cells, cancer cells rely on the TCA cycle for the production of metabolic intermediates for the generation of fatty acids and nucleotides. At least three mitochondrial pathways are involved in pyrimidine and purine nucleotide synthesis, and the rate-limiting step in de novo synthesis of pyrimidines occurs in mitochondria and is linked to respiratory chain activity (Desler et al., 2010) . To determine whether mitochondrial hypo-function in response to InsP 3 R inhi- bition compromises nucleotide metabolism that may contribute to cancer cell death, HrasG12V-CDK4 fibroblasts were treated with 5 mM XeB for 24 hr in media supplemented with nucleosides. Notably, nucleoside supplementation was strongly protective of XeB-treated HrasG12V-CDK4 cells ( Figure 5A ), despite enhanced P-AMPK phosphorylation and autophagy activation ( Figures 5B-5E ). Thus, with nucleoside supplementation, cancer cells behave as normal cells, surviving in the face of an unfavorable bioenergetic state.
Nucleosides contribute to the purine and pyrimidine generation necessary for DNA synthesis. In normal fibroblasts, XeB (5 mM, 10 hr) reduced bromodeoxyuridine (BrdU) incorporation by >50% (Figure 5F ), suggesting that the unfavorable bioenergetic state in the absence of Ca 2+ transfer to mitochondria slowed cell proliferation, as expected. In marked contrast, XeB had minimal effects on BrdU incorporation into HrasG12V-CDK4 cells ( Figure 5G ). These results suggest that normal cells restrain entry into the S phase when conditions are unsuitable, but transformed cells do not recognize this checkpoint. Because of the enforced expression of Cdk4 in HrasG12V-CDK4 cells, it remained unclear whether other cancer cells would progress similarly into mitosis during a XeB-induced compromised bioenergetic state. XeB (5 mM, 24 hr) increased the population of MCF10A cells in the G1 phase that correlated with a decrease proceeding through the S phase ( Figure 5H ), as observed in normal human primary fibroblasts. In contrast, MCF7 cells showed no increase of the G1 population and only a slight decrease in cells in the S phase ( Figure 5I ). This suggests that MCF7 cells, like HrasG12V-CDK4 cells but unlike normal cells, proceed through the cell cycle, despite their compromised bioenergetic state. Similar behavior was observed in HeLa cells, a common cervical tumor cell line ( Figure 5J ). HeLa cells were optically imaged to observe progression through the cell cycle. Remarkably, XeB-treated cells entered mitosis but then collapsed catastrophically and died during daughter cell separation (n = 30 mitoses) ( Figure 5L ; Movie S3), a phenotype never observed in vehicle-treated cells (n = 50 mitoses). This suggests that, in cells with InsP 3 R activity inhibited or mitochondrial Ca 2+ uptake otherwise blocked, cancer cells progress through the cell cycle, despite their bioenergetic crisis, in contrast to normal cells that stop in the G1 phase, and their progression into mitosis appears to be a step that results in cell death. To probe this further, MCF7 cells were incubated with 400 mM hydroxyurea (HU) to arrest them in the S phase of the cell cycle ( Figure S5A ) and then were treated with 5 mM XeB for 24 hr. As shown in Figure 5K , the prevention of cell-cycle progression strongly decreased cell death induced by XeB.
Cell Death Induced by Inhibition of InsP 3 R Ca 2+ Signaling Is Mainly Necrotic Our results reveal that inhibition of InsP 3 R-mediated Ca 2+ transfer to mitochondria causes death, specifically in tumorigenic cells, but how they die is unknown. Autophagy inhibition with 3-methyladenine (3MA) ( Figures S5B and S5C ) did not prevent cell death in XeB-treated MCF7 and MCF10A cells ( Figure 6A ) and in normal and HrasG12V-CDK4 fibroblasts ( Figure 6B ), suggesting that autophagy is not driving cell death. Although 3MA tended to increase cell death in XeB-treated MCF10A cells and normal fibroblasts, suggesting that autophagy plays a cell survival role, as previously suggested (Cá rdenas et al., 2010), KD of ATG7 ( Figures S5D and S5E ) did not influence the extent of cell death ( Figure S5F ). Inhibition of apoptosis with the pan-caspase inhibitor Z-VAD-FMK did not protect tumorigenic cells from XeB-induced death ( Figures 6A and 6B) . Furthermore, western blot and immunofluorescence analyses of activated cleaved caspase-3 in human normal and HrasG12V-CDK4 fibroblasts 
001; NS, not significant (Student's t test). (E) Representative western blots of AMPK in normal (N) and transformed (T) fibroblasts transiently
transfected with a siRNA against type 1 and type 3 InsP 3 R (IP3R) for 24 hr or siRNA against MCU for 72 hr. Bar graph: P-AMPK/AMPK expressed as the average fold increase over basal levels (S cells). n = 3, mean ± SEM. ***p < 0.001 (Student's t test).
(F) Representative western blots of LC3 and tubulin in normal (N) and transformed (T) fibroblasts transiently transfected with a siRNA against type 1 and type 3 InsP 3 R for 24 hr or siRNA against MCU for 72 hr, or scrambled sRNAs (S); LC3-II/ tubulin expressed as average fold increase over basal levels (S cells). n = 3, mean ± SEM. ***p < 0.001 (Student's t test). (G) Determination of cell death by LDH release in normal and transformed fibroblasts transiently transfected with a siRNA against type 1 and type 3 InsP 3 R for 24 hr or siRNA against MCU for 72 hr. n = 3, mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001 (Student's t test). (H) Determination of cell death by LDH release in normal and transformed fibroblasts treated simultaneously with 5 mM XeB and either 5 mM methyl-pyruvate (Pyr) or 5 mM dimethyl a-KG (Keto) for 24 hr. n = 3, mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant (Student's t test). See also Figure S4. ( Figure S5G ), and in tumor samples ( Figure S5H ), similarly suggested that apoptosis is not a major feature associated with cell killing. Flow cytometry analyses using fluorescein isothiocyanate (FITC)-Annexin V and propidium iodide (PI) labeling further confirmed the presence of only a small apoptotic cell population after XeB treatment ( Figure S5I ). Inhibition of necroptosis with necrostatin also did not prevent XeB-induced cell death ( Figures  6A and 6B) . The transcription factor HMGB1 is normally localized in the nucleus but is released into the cytoplasm during early stages of necrosis (Scaffidi et al., 2002) . Most (>50%) MCF7 cells exposed to 5 mM XeB for 24 hr lost nuclear labeling, while untreated cells and treated MCF10A cells overwhelmingly maintained nuclear HMGB1 labeling ( Figures 6C and 6D) . Together with the imaging data, these results suggest that, in response to the inhibition of Ca 2+ transfer to mitochondria, cancer cells die by necrosis, at approximately the time of daughter cell separation in mitosis.
Inhibition of InsP 3 R Activity Impairs Tumor Growth in Nude Mice
To evaluate whether InsP 3 R inhibition affected tumor growth in vivo, subcutaneous tumors were generated using B16F10 Figures S2F and S2G) . OCR was inhibited (Figure S2H) , and LDH release was increased in a dose-dependent manner by a 24-hr exposure to XeB ( Figure S2I ). Thus, this cell line is appropriate to examine in vivo. B16F10 cells were injected subcutaneously into ventral flanks of 5-to 6-week-old nu/nu mice. When tumors were palpable, usually by day 5 post-injection, one tumoral flank was injected with 100 ml of a solution of 100 mM XeB, and the other was injected with vehicle (PBS plus ethanol). One day later, mice were euthanized, and tumors were extracted and weighed ( Figure S6A, treatment 1) . XeB reduced tumor size by nearly 60% in comparison to untreated tumors ( Figure 7A ). In a different paradigm, one tumoral flank was treated every other day for a week with 100 ml of a solution of 100 mM XeB ( Figure S6A, treatment 2) . XeB reduced tumor size by 70%, compared with untreated tumors ( Figure 7B ). Markers of bioenergetic stress normally observed after InsP 3 R inhibition, including enhanced AMPK phosphorylation and autophagy, were observed in the XeB-injected tumor sections ( Figures  S6B and S6C) . The vast majority of XeB-treated tumor cells lost HMGB1 nuclear localization, whereas control tumor cells had HMGB1 largely in the nucleus ( Figure 7C ). Ki67, a marker of cell proliferation, labeled nuclei equivalently in both XeBand vehicle-treated tumors ( Figure 7D) , consistent with the idea that tumor cells remain committed to enter the cell cycle, even when in a state of compromised bioenergetics caused by inhibition of InsP 3 R activity. 
DISCUSSION
The main result of the present study is the demonstration of a unique requirement of tumorigenic cancer cells for constitutive ER-to-mitochondria Ca 2+ transfer for their survival. In the absence of this transfer, either as a consequence of blocking InsP 3 R-mediated Ca 2+ release or blocking mitochondrial Ca 2+ uptake, all tumor cells examined experienced a bioenergetic crisis similar to that of normal cells, but activation of autophagy, which enabled normal cells to survive, was insufficient, and the tumor cells died by necrosis as they proceeded through mitosis. Specific cancer cell killing was observed in human tumorigenic cell lines derived from breast, prostate, and cervix (HeLa), as well as, in data not shown, bone (143B), colon (SW480 and Colo320), kidney (RCCC), skin (WM3918, A231, WM239a, and B16F10), and brain (T98G) cancers. In addition, the same effect was observed in isogenic primary human fibroblasts transformed by expression of oncogenic Ras and enforced expression of Cdk4, a relevant combination found in spontaneous human cancers (Ridky et al., 2010) . Furthermore, inhibition of InsP 3 R activity had strong anti-tumor efficacy in vivo.
Increased InsP 3 R expression and/or activity has been associated with cancer cell proliferation, growth, survival, and migration (Davis et al., 2013; Kang et al., 2010; Messai et al., 2014; Shibao et al., 2010; Szatkowski et al., 2010) . Furthermore, MCU is highly expressed in ER-negative and basal-like breast cancers (Sørlie et al., 2006) . Our results suggest that the fatal fate of cancer cells after InsP 3 R inhibition is a result of mitochondrial dysfunction, but it is independent of apoptotic mechanisms and, instead, appears linked to metabolic defects. Constitutive InsP 3 R-mediated Ca 2+ release is essential to support activity of PDH, a key enzyme that controls the flux of carbon into the TCA cycle, through Ca 2+ activated PDH phosphatase activity. Consequently, diminished TCA production of NADH leads to lower rates of OXPHOS and a decline in ATP levels (Cá rdenas et al., 2010) . It is now recognized that most cancer cells rely on mitochondrial metabolism and use a significant fraction of glucose-derived pyruvate for ATP generation and for anaplerotic reactions to replenish TCA-cycle precursors for macromolecular biosynthesis (Ahn and Metallo, 2015; Jose et al., 2011; Koppenol et al., 2011; Moreno-Sá nchez et al., 2007; Porporato et al., 2014) . OXPHOS is important for ATP production in many cancers ( Vander Heiden, 2013) . Pancreatic cancer (Viale et al., 2014) and leukemic (Lagadinou et al., 2013; Nakada et al., 2010; Shi et al., 2012; Skrti c et al., 2011; Yang et al., 2011) stem cells, diffuse large B cell tumors (Caro et al., 2012) , and primary glioblastoma sphere cultures (Janiszewska et al., 2012) rely on OXPHOS for survival. Primary human glioblastomas oxidize glucose via PDH and the TCA cycle during aggressive tumor growth (Marin-Valencia et al., 2012) . Inhibition of complex 1 inhibits respiration and human cancer cell growth (Wheaton et al., 2014) . The TCA cycle is also critically important in cancer cells for the generation of biochemical intermediates to sustain high rates of proliferation (Deberardinis et al., 2008) . Most cancer cells derive lipogenic acetyl-coenzyme A (CoA) from pyruvate through Ca 2+ -dependent PDH (Hatzivassiliou et al., 2005; Metallo et al., 2012) , and activation of PDH can promote cancer cell senescence (Kaplon et al., 2013) . Some cancers have defective OXPHOS but, nevertheless, rely on the TCA cycle (Mullen et al., 2012 (Mullen et al., , 2014 . Even in cancer cells with mutations in the TCA cycle, the turnover of TCA cycle intermediates is maintained (Mullen et al., 2012) . Most cancer cells use PDH as well as glutamine to fuel the TCA cycle (DeBerardinis et al., 2007) , where it enters and then cycles through a-KGDH as the first step (Mullen et al., 2014) . Importantly, a-KGDH activity is strongly Ca 2+ dependent (Armstrong et al., 2014) , with apparent affinity similar to that of PDH phosphatase, suggesting that it may also be reduced by interruption of ER-to-mitochondria Ca 2+ transfer.
Reductive carboxylation of a-KG is observed in many cancer cells with impaired OXPHOS, where it maintains levels of biosynthetic intermediates. Notably, reductive carboxylation of a-KG requires its oxidation by Ca 2+ -dependent a-KGDH (Mullen et al., 2014) . Furthermore, reduction of a-KG to isocitrate is mediated by IDH, the other Ca 2+ dependent enzyme in the TCA cycle. It is of interest that nucleotide supplementation prevented cancer cell death. a-KG is a precursor for glutamine and aspartate necessary for pyrimidine synthesis that requires mitochondrial dihydrooroate, which, in turn, requires flux through the electron transport chain (Grassian et al., 2014; Mullen et al., 2014 (Ciapa et al., 1994; Han et al., 1992; Miller et al., 1993; Resende et al., 2010) . Conversely, its inhibition Tumors were generated by subcutaneous injection of murine-melanoma-derived B16F10 cells into nude mice.
(A) Tumor weight in mice with tumors injected with 100 ml of a 100-mM XeB solution 1 day before euthanization. n = 9, mean ± SEM. *p < 0.05 (Student's t test).
(B) Tumor weight in mice with tumors injected with 100 ml of a 100-mM XeB solution or vehicle every other day for 6 days before euthanization. n = 9, mean ± SEM. *p < 0.05 (Student's t test).
(C) HMGB1 immunofluorescence in tumors injected, or not injected, with 100 ml of a 100-mM XeB solution 1 day before euthanization. The control tumor shows strong nuclear labeling (arrows), while in the XeB-treated tumor, the nuclei appear empty (arrows), with remaining labeling cytosolic or extracellular. n = 3. Scale bar represents 10 mm.
(D) Ki67 immunofluorescence in tumors injected, or not injected, with 100 ml of a 100-mM XeB solution 1 day before euthanization. Left: panoramic view of control and XeB-treated tumors. Scale bar represents 100 mm. Right: detail of control and XeB-treated tumors. Scale bar represents 10 mm. n = 3. See also Figure S6 .
activates AMPK (Cá rdenas et al., 2010 ; and discussed in the present study), which can phosphorylate and activate p53 to induce p21 waf1/cip1 -mediated cell-cycle arrest (Jones et al., 2005 , 2010) . Thus, it remains unclear why proliferation was not reduced in tumorigenic cells in response to inhibition of InsP 3 R activity. Importantly, progression into mitosis resulted in catastrophic cell death during cytokinesis of all the tumor cells examined. Necrosis as the mechanism of cell death was confirmed by biochemical and histological markers in the cell lines, primary cells, and solid tumors. In contrast, neither apoptosis nor autophagy, nor necroptosis, appeared to play significant roles. The mechanisms that lead to mitotic catastrophic cell death (Vitale et al., 2011) around the time of cytokinesis remain to be determined. Interactions of the cyclin-dependent kinase substrate CP110 with Ca 2+ -binding proteins calmodulin or centrin are essential for correct cytokinesis. Whereas the presence of a CP110 mutant unable to bind calmodulin induces cytokinesis failure and multinucleated cells (Tsang et al., 2006) , it is possible that cytokinesis failure in the face of a bioenergetic crisis results, instead, in necrotic mitotic catastrophe. The failure of the tumorigenic cells to slow cell proliferation, despite the fact that they were in an energetically compromised state, appears to be the major mechanism that distinguishes them from non-tumorigenic cells and accounts for their susceptibility to cell killing. 
Microscopy
Details of microscopy are available in the Supplemental Information.
Oxygen Consumption OCR was measured at 37 C using an XF24 extracellular analyzer (Seahorse Bioscience). Details are provided in the Supplemental Information.
Clonogenic Assay
Colony formation was assayed as described previously (Franken et al., 2006) with details provided in the Supplemental Information.
Cell Cycle Analysis
Details are provided in the Supplemental Information.
Cell Death
Cell death was determined by LDH activity release by a colorimetric assay according to the manufacturer's instructions (Roche) and by PI (final concentration, 2.5 mg/ml) exclusion by flow cytometry (BD FACSCanto, BD Biosciences).
Mouse Tumor Generation and Histochemistry
All in vivo experiments were conducted with the approval of the University of Pennsylvania Institutional Animal Care and Use Committee. Murine-melanoma-derived B16F10 cells (1 3 10 5 cells) were subcutaneously injected into flanks of immunodeficient mice, and after 1 week, visible tumors were observed. Tumors of one flank were injected with 100 ml of a 100-mM XeB solution, and those on the contralateral side were left untreated or injected with 1% EtOH in PBS. Mice were euthanized after 1 day or 6 days of treatment with XeB, and tumors were extracted, weighed, and processed for immunohistochemistry.
Lactate Measurements
Cell lactate was measured colorometrically (Abcam) according to the manufacturer's instructions.
Glucose Uptake
Fibroblasts were washed with Krebs-BSA buffer, pre-incubated (or not) with cytochalasin B (10 min), and incubated for 10 min at 37 C with 10 mM 3 H-2-deoxyglucose. The reaction was stopped by placing it on ice, and the samples were spun, decanted, lysed in 1% Triton X-100, and cell 3 H quantified.
Analysis and Statistics
All data are summarized as means ± SEM; significance of differences was assessed using unpaired Student's t tests. Differences were accepted as significant at the 95% level (p < 0.05).
